$25m IPO envisioned for ‘magic mushrooms’ to treat depression
A healthcare investment firm that’s backing studies of “magic mushrooms” to treat depression raised $25m of capital… …already in talks with banks about a potential listing in Canada next year, a step for which it seeks a valuation of $800m or more, according to one of the people familiar with the matter. After being shunned…
Recent Comments